Takeda: all 1,753 studies

Page 8 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy ParticipantsCompletedNCT01879722Phase 1Results posted
• A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorCompletedNCT01874665Phase 2Results posted
• Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid TumorsCompletedNCT01862328Phase 1Results posted
• IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01850524Phase 3Results posted
• Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous InsufficiencyCompletedNCT01848210Phase 4Results posted
• Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of AlisertibCompletedNCT01844583Phase 1Results posted
• Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher DiseaseCompletedNCT01842841Phase 3Results posted
• Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 DiabetesTerminatedNCT01834274Phase 3Results posted
• Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal ImpairmentCompletedNCT01830816Phase 1Results posted
• Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 DiabetesTerminatedNCT01829477Phase 3Results posted
• TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 DiabetesTerminatedNCT01829464Phase 3Results posted
• AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184CompletedNCT01824446Phase 1Results posted
• Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or OlderCompletedNCT01814826Phase 1Results posted
• Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in VolunteersCompletedNCT01807000Phase 1Results posted
• An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis AccessTerminatedNCT01806584Phase 2Results posted
• An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis AccessCompletedNCT01806545Phase 2Results posted
• Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in VolunteersCompletedNCT01786876Phase 1Results posted
• Long-Term Safety Of PF-00547659 In Ulcerative ColitisCompletedNCT01771809Phase 2Results posted
• Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet InjectorCompletedNCT01765426Phase 1Results posted
• The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable AnginaCompletedNCT01763996Phase 4Results posted
• Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaTerminatedNCT01760993Phase 3Results posted
• SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaTerminatedNCT01760889Phase 3Results posted
• Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand RegimenCompletedNCT01757405Phase 3Results posted
• Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema AttacksCompletedNCT01756157Phase 2Results posted
• A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry EyeCompletedNCT01743729Phase 3Results posted
• Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of SchizophreniaTerminatedNCT01738698Phase 3Results posted
• Long-Term Study of IGIV, 10% in Alzheimer´s DiseaseTerminatedNCT01736579Phase 3Results posted
• Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)CompletedNCT01736475Phase 2/3Results posted
• Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel PreparationCompletedNCT01732692Phase 3Results posted
• Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver FunctionCompletedNCT01732263Phase 1Results posted
• Impact of SC vs IM Administration of DENVax (TDV) on Safety and ImmunogenicityCompletedNCT01728792Phase 1Results posted
• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCompletedNCT01718509Phase 3Results posted
• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCompletedNCT01718483Phase 3Results posted
• Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal FunctionCompletedNCT01716455Phase 1Results posted
• Mass Balance, Pharmacokinetics and Metabolism Study of AlisertibCompletedNCT01714947Phase 1Results posted
• A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin LymphomaCompletedNCT01712490Phase 3Results posted
• Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon ActivityCompletedNCT01707667Phase 4Results posted
• A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on DialysisCompletedNCT01696279Phase 2Results posted
• Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher DiseaseCompletedNCT01685216Phase 1/2Results posted
• Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 DisorderTerminatedNCT01677182Phase 3Results posted
• Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184)TerminatedNCT01671111Phase 2Results posted
• A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)CompletedNCT01667133Phase 1/2Results posted
• Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate CancerCompletedNCT01666314Phase 1/2Results posted
• Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) AmyloidosisTerminatedNCT01659658Phase 3Results posted
• Open Label Extension in Adults With Binge Eating Disorder (BED)CompletedNCT01657019Phase 3Results posted
• GLASSIA Infusion Rate StudyCompletedNCT01651351Phase 4Results posted
• Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)TerminatedNCT01650805Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 DiabetesTerminatedNCT01647542Phase 3Results posted
• Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple MyelomaCompletedNCT01645930Phase 1Results posted
• Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in AdolescentsCompletedNCT01642615Phase 2Results posted
• Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in AdolescentsCompletedNCT01642602Phase 2Results posted
• OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label ExtensionCompletedNCT01642212Phase 2Results posted
• Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy ParticipantsCompletedNCT01639222Phase 1Results posted
• Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II DiabetesCompletedNCT01637935Results posted
• Safety Study of Lifitegrast to Treat Dry EyeCompletedNCT01636206Phase 3Results posted
• A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative ColitisCompletedNCT01620255Phase 2Results posted
• Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher DiseaseCompletedNCT01614574Phase 3Results posted
• Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant RecipientsCompletedNCT01611974Phase 2Results posted
• Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseTerminatedNCT01609582Phase 3Results posted
• Norovirus Bivalent-Vaccine Efficacy StudyCompletedNCT01609257Phase 1/2Results posted
• Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation TherapyTerminatedNCT01604941Phase 2Results posted
• Drug Interaction Study of Colchicine and TheophyllineCompletedNCT01601132Phase 4Results posted
• Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)CompletedNCT01582854Phase 3Results posted
• A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)CompletedNCT01578499Phase 3Results posted
• Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase CCompletedNCT01577758Phase 1Results posted
• Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive DisorderCompletedNCT01564862Phase 2Results posted
• A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaCompletedNCT01564537Phase 3Results posted
• A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021CompletedNCT01560403Phase 3Results posted
• Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy VolunteersCompletedNCT01552928Phase 1Results posted
• Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderCompletedNCT01552915Phase 4Results posted
• Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderCompletedNCT01552902Phase 4Results posted
• Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable AnginaTerminatedNCT01549977Phase 2Results posted
• Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 DiabetesTerminatedNCT01549964Phase 3Results posted
• Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01549951Phase 2Results posted
• A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast CancerCompletedNCT01546649Phase 3Results posted
• A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal TherapyCompletedNCT01546623Phase 3Results posted
• A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult VolunteersCompletedNCT01542632Phase 1Results posted
• Phase 3 IGIV, 10% in Alzheimer´s DiseaseTerminatedNCT01524887Phase 3Results posted
• Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCompletedNCT01518946Phase 4Results posted
• Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCompletedNCT01515865Phase 4Results posted
• A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or LymphomasCompletedNCT01512758Phase 1Results posted
• Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 YearsCompletedNCT01511250Phase 2Results posted
• Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)CompletedNCT01510028Phase 1/2Results posted
• BAX 326 Surgery Study in Hemophilia B PatientsCompletedNCT01507896Phase 3Results posted
• An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive ImpairmentCompletedNCT01506141Phase 1/2Results posted
• Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in EuropeCompletedNCT01500694Phase 3Results posted
• Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular SurgeryCompletedNCT01500135Phase 3Results posted
• Effect of Febuxostat on Blood PressureCompletedNCT01496469Phase 2Results posted
• Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and DiabetesTerminatedNCT01496430Phase 3Results posted
• Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin LymphomaCompletedNCT01492088Phase 1/2Results posted
• BAX 326 Pediatric StudyCompletedNCT01488994Phase 2/3Results posted
• Tolerability and Safety of IGI, 10% With rHuPH20 in PIDDCompletedNCT01485796Phase 2/3Results posted
• Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell LymphomaCompletedNCT01482962Phase 3Results posted
• Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 DiabetesTerminatedNCT01481116Phase 3Results posted
• Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on DialysisCompletedNCT01478971Phase 3Results posted
• Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedNCT01472939Phase 2Results posted
• SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)CompletedNCT01470469Phase 2Results posted
• Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/MesalamineCompletedNCT01469637Phase 1Results posted
• Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I DisorderTerminatedNCT01467713Phase 3Results posted
• Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I DisorderTerminatedNCT01467700Phase 3Results posted

← Takeda overview and focus areas